F Dx Advisors, Inc. Icon PLC Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

A detailed history of F Dx Advisors, Inc. transactions in Icon PLC stock. As of the latest transaction made, F Dx Advisors, Inc. holds 3,105 shares of ICLR stock, worth $621,062. This represents 0.24% of its overall portfolio holdings.

Number of Shares

3,105

Previous 3,233 3.96%

Holding current value

$621,062

Previous $1.01 Million 11.94%

% of portfolio

0.24%

Previous 0.28%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$280.48 - $346.2 $35,901 - $44,313	-128 Reduced 3.96%	3,105 $892,000
Q2 2024 Aug 02, 2024	SELL	$288.23 - $331.73 $84,163 - $96,865	-292 Reduced 8.28%	3,233 $1.01 Million
Q1 2024 May 03, 2024	SELL	$247.84 - $340.0 $845,382 - $1.16 Million	-3,411 Reduced 49.18%	3,525 $1.18 Million
Q4 2023 Feb 12, 2024	SELL	$222.83 - $285.76 $43,006 - $55,151	-193 Reduced 2.71%	6,936 $1.96 Million
Q3 2023 Nov 02, 2023	SELL	$236.44 - $265.62 $106,398 - $119,529	-450 Reduced 5.94%	7,129 $1.76 Million
Q2 2023 Jul 17, 2023	SELL	$183.12 - $250.2 $560,713 - $766,112	-3,062 Reduced 28.78%	7,579 $1.9 Million
Q4 2022 Feb 09, 2023	SELL	$173.9 - $224.8 $267,806 - $346,192	-1,540 Reduced 12.64%	10,641 $2.07 Million
Q3 2022 Nov 10, 2022	SELL	$183.25 - $247.5 $488,361 - $659,587	-2,665 Reduced 17.95%	12,181 $2.24 Million
Q2 2022 Aug 03, 2022	BUY	$197.3 - $261.32 $86,417 - $114,458	438 Added 3.04%	14,846 $3.22 Million
Q1 2022 May 03, 2022	SELL	$216.09 - $296.03 $1.03 Million - $1.42 Million	-4,783 Reduced 24.92%	14,408 $3.5 Million
Q4 2021 Feb 01, 2022	BUY	$258.11 - $309.7 $82,595 - $99,104	320 Added 1.7%	19,191 $5.94 Million
Q3 2021 Oct 08, 2021	BUY	$208.53 - $283.04 $635,599 - $862,705	3,048 Added 19.26%	18,871 $4.95 Million
Q2 2021 Aug 05, 2021	BUY	$194.07 - $232.2 $189,024 - $226,162	974 Added 6.56%	15,823 $3.27 Million
Q1 2021 Apr 14, 2021	BUY	$171.87 - $220.96 $2.05 Million - $2.64 Million	11,933 Added 409.22%	14,849 $2.92 Million
Q1 2021 Apr 13, 2021	SELL	$171.87 - $220.96 $1.18 Million - $1.52 Million	-6,876 Reduced 70.22%	2,916 $572,000
Q4 2020 Feb 08, 2021	BUY	$180.3 - $214.08 $246,109 - $292,219	1,365 Added 16.2%	9,792 $1.91 Million
Q3 2020 Nov 12, 2020	SELL	$166.91 - $196.1 $107,490 - $126,288	-644 Reduced 7.1%	8,427 $1.61 Million
Q2 2020 Jul 22, 2020	SELL	$129.79 - $170.94 $58,794 - $77,435	-453 Reduced 4.76%	9,071 $1.53 Million
Q1 2020 May 22, 2020	SELL	$115.95 - $177.22 $252,075 - $385,276	-2,174 Reduced 18.58%	9,524 $1.3 Million
Q1 2020 May 13, 2020	BUY	$115.95 - $177.22 $318,166 - $486,291	2,744 Added 30.65%	11,698 $447,000
Q4 2019 Feb 12, 2020	BUY	$139.48 - $172.23 $368,924 - $455,548	2,645 Added 41.92%	8,954 $1.54 Million
Q3 2019 Nov 07, 2019	SELL	$146.89 - $161.41 $90,190 - $99,105	-614 Reduced 8.87%	6,309 $930,000
Q2 2019 Jul 19, 2019	BUY	$129.99 - $153.97 $148,838 - $176,295	1,145 Added 19.82%	6,923 $1.07 Million
Q1 2019 May 14, 2019	BUY	$121.3 - $146.95 $23,774 - $28,802	196 Added 3.51%	5,778 $789,000
Q4 2018 Apr 29, 2019	SELL	$119.37 - $153.29 $561,993 - $721,689	-4,708 Reduced 45.75%	5,582 $721,000
Q4 2018 Feb 07, 2019	BUY	$119.37 - $153.29 $130,590 - $167,699	1,094 Added 11.9%	10,290 $1.33 Million
Q3 2018 Nov 13, 2018	BUY	$131.3 - $153.75 $142,723 - $167,126	1,087 Added 13.4%	9,196 $1.41 Million
Q2 2018 Aug 08, 2018	SELL	$111.38 - $137.03 $913,984 - $1.12 Million	-8,206 Reduced 50.3%	8,109 $1.08 Million
Q1 2018 May 02, 2018	SELL	$103.82 - $123.9 $398,980 - $476,147	-3,843 Reduced 19.06%	16,315 $1.93 Million
Q4 2017 Feb 09, 2018	BUY	$111.14 - $123.05 $28,340 - $31,377	255 Added 1.28%	20,158 $2.26 Million
Q3 2017 Nov 03, 2017	SELL	$101.4 - $116.62 $94,606 - $108,806	-933 Reduced 4.48%	19,903 $2.27 Million
Q2 2017 Aug 11, 2017	BUY	N/A	20,836	20,836 $2.04 Million

Others Institutions Holding ICLR

# of Institutions

700

Shares Held

75.7M

Call Options Held

141K

Put Options Held

55.1K

View Full List

About ICON PLC

Ticker ICLR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 81,526,600
Market Cap $16.3B
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...

More about ICLR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account